Karyopharm Presents Positive Phase 1/2 Eltanexor Data at the American Society of Hematology 2017 Annual Meeting

Dec 10, 2017 23:05 pm UTC| Business

− Preliminary Data Show that Eltanexor is Well Tolerated and Demonstrates Promising Activity in Multiple Myeloma – − Expanding Program to Include Colorectal Cancer, Castration-resistant Prostate Cancer, and...

Karyopharm Presents Positive Selinexor Data from the Phase 1b/2 STOMP Study at the American Society of Hematology 2017 Annual Meeting

Dec 10, 2017 23:00 pm UTC| Business

− Data Provide Further Evidence of Tolerability with Robust Anti-Myeloma Activity When Selinexor is Combined with Velcade, Pomalyst, Revlimid or Darzalex – − SVd Arm Continues to Show High Response Rates, Including 83%...

Agios Presents Updated Data from DRIVE PK Study Demonstrating AG-348 is Well-Tolerated and Results in Clinically Relevant, Rapid and Sustained Hemoglobin Increases in Patients with Pyruvate Kinase Deficiency

Dec 10, 2017 23:00 pm UTC| Business

– Safety and Efficacy Profile Consistent with Previously Reported Data –  – Hemoglobin Increases 1.0 g/dL in 26 of 52 Patients Overall; Responses Remain Durable with Completion of Six Month Core Treatment Period – – Two...

ZIOPHARM Announces Presentation of Data from T-Cell Therapy Programs at ASH Annual Meeting

Dec 10, 2017 22:00 pm UTC| Business

– Clinical data show continued survival benefit, tumor response, and multi-year persistence of Sleeping Beauty-modified CD19-specific CAR+ T cells –– Point-of-care CD19-specific CAR+ T cells co-expressing mbIL15 with...

Algeco Scotsman Announces Debt Package for Refinancing, Acquisition of Touax Solutions Modulaires SAS and Exercise of Put Option

Dec 10, 2017 21:45 pm UTC| Business

BALTIMORE, Md., Dec. 10, 2017 -- Algeco/Scotsman Holding S.à r.l. (together with its subsidiaries, the “Algeco Group”) today announced that a finance special purpose vehicle that will be a subsidiary of the Algeco Group...

Exclusive: Today, 9 December 2017, Artprice confirms that the acquisition of Da Vinci's Salvator Mundi involved geopolitical mediation, and that the Vatican Museums did indeed study the offer

Dec 10, 2017 20:59 pm UTC| Business

Artprice confirms the contents of its press release of 8 December and, today (9 December), adds further explanations concerning this historic sale: Artprice Exclusive - Da Vinci's Salvator Mundi at the Louvre Abu...

Epizyme Presents New Biomarker Data on Tazemetostat at the American Society of Hematology Annual Meeting

Dec 10, 2017 15:00 pm UTC| Business

CAMBRIDGE, Mass., Dec. 10, 2017 -- Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage biopharmaceutical company developing novel epigenetic therapies, today announced that two presentations reinforcing its commitment to...